Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer

MLA

Houben, J., et al. “Patient Reported Toxicity and Quality of Life after Hypofractionated High-Dose Intensity-Modulated Radiotherapy for Intermediate- and High Risk Prostate Cancer.” Clinical and Translational Radiation Oncology, 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280202540&authtype=sso&custid=ns315887.

APA

Houben, J., McColl, G., Kaanders, J. H., & Smeenk, R. J. (2021). Patient reported toxicity and quality of life after hypofractionated high-dose intensity-modulated radiotherapy for intermediate- and high risk prostate cancer. Clinical and Translational Radiation Oncology.

Chicago

Houben, J., G. McColl, J.H. Kaanders, and R.J. Smeenk. 2021. “Patient Reported Toxicity and Quality of Life after Hypofractionated High-Dose Intensity-Modulated Radiotherapy for Intermediate- and High Risk Prostate Cancer.” Clinical and Translational Radiation Oncology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1280202540&authtype=sso&custid=ns315887.